Australia is closely watching the arrival of retatrutide, a novel dual GIP and GLP-1 receptor medication , representing a significant advance in obesity treatment . Early clinical trials have demonstrated https://giant-defy-road-bike356060.thecomputerwiki.com/6807613/emerging_medication_in_australia_a_potential_hope_for_obesity_management